These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 19936237)

  • 21. Amyloid precursor protein cytoplasmic domain with phospho-Thr668 accumulates in Alzheimer's disease and its transgenic models: a role to mediate interaction of Abeta and tau.
    Shin RW; Ogino K; Shimabuku A; Taki T; Nakashima H; Ishihara T; Kitamoto T
    Acta Neuropathol; 2007 Jun; 113(6):627-36. PubMed ID: 17431643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta-amyloid treatment of two complementary P301L tau-expressing Alzheimer's disease models reveals similar deregulated cellular processes.
    David DC; Ittner LM; Gehrig P; Nergenau D; Shepherd C; Halliday G; Götz J
    Proteomics; 2006 Dec; 6(24):6566-77. PubMed ID: 17111439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age-dependent impact of streptozotocin on metabolic endpoints and Alzheimer's disease pathologies in 3xTg-AD mice.
    Canet G; Gratuze M; Zussy C; Bouali ML; Diaz SD; Rocaboy E; Laliberté F; El Khoury NB; Tremblay C; Morin F; Calon F; Hébert SS; Julien C; Planel E
    Neurobiol Dis; 2024 Aug; 198():106526. PubMed ID: 38734152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models.
    Zhang Q; Zhang X; Sun A
    Acta Neuropathol; 2009 Jun; 117(6):687-97. PubMed ID: 19190923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurofibrillary tangle-bearing neurons are functionally integrated in cortical circuits in vivo.
    Kuchibhotla KV; Wegmann S; Kopeikina KJ; Hawkes J; Rudinskiy N; Andermann ML; Spires-Jones TL; Bacskai BJ; Hyman BT
    Proc Natl Acad Sci U S A; 2014 Jan; 111(1):510-4. PubMed ID: 24368848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Granulovacuolar degeneration and unfolded protein response in mouse models of tauopathy and Aβ amyloidosis.
    Köhler C; Dinekov M; Götz J
    Neurobiol Dis; 2014 Nov; 71():169-79. PubMed ID: 25073087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substrate-specific reduction of PP2A activity exaggerates tau pathology.
    Deters N; Ittner LM; Götz J
    Biochem Biophys Res Commun; 2009 Feb; 379(2):400-5. PubMed ID: 19126401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amyloid precursor protein reduction enhances the formation of neurofibrillary tangles in a mutant tau transgenic mouse model.
    Vanden Dries V; Stygelbout V; Pierrot N; Yilmaz Z; Suain V; De Decker R; Buée L; Octave JN; Brion JP; Leroy K
    Neurobiol Aging; 2017 Jul; 55():202-212. PubMed ID: 28464981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
    Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
    Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice.
    Oddo S; Caccamo A; Cheng D; Jouleh B; Torp R; LaFerla FM
    J Neurochem; 2007 Aug; 102(4):1053-63. PubMed ID: 17472708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain-Wide Insulin Resistance, Tau Phosphorylation Changes, and Hippocampal Neprilysin and Amyloid-β Alterations in a Monkey Model of Type 1 Diabetes.
    Morales-Corraliza J; Wong H; Mazzella MJ; Che S; Lee SH; Petkova E; Wagner JD; Hemby SE; Ginsberg SD; Mathews PM
    J Neurosci; 2016 Apr; 36(15):4248-58. PubMed ID: 27076423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Region-Specific Vulnerability to Oxidative Stress, Neuroinflammation, and Tau Hyperphosphorylation in Experimental Diabetes Mellitus Mice.
    Elahi M; Hasan Z; Motoi Y; Matsumoto SE; Ishiguro K; Hattori N
    J Alzheimers Dis; 2016; 51(4):1209-24. PubMed ID: 26923011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of the cholinergic pathology in the P301L tau transgenic pR5 model of tauopathy.
    Köhler C; Bista P; Götz J; Schröder H
    Brain Res; 2010 Aug; 1347():111-24. PubMed ID: 20513372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing mice.
    Plaschke K; Kopitz J; Siegelin M; Schliebs R; Salkovic-Petrisic M; Riederer P; Hoyer S
    J Alzheimers Dis; 2010; 19(2):691-704. PubMed ID: 20110613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experimentally induced diabetes worsens neuropathology, but not learning and memory, in middle aged 3xTg mice.
    Hayashi-Park E; Ozment BN; Griffith CM; Zhang H; Patrylo PR; Rose GM
    Behav Brain Res; 2017 Mar; 322(Pt B):280-287. PubMed ID: 27173425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccination with Sarkosyl insoluble PHF-tau decrease neurofibrillary tangles formation in aged tau transgenic mouse model: a pilot study.
    Ando K; Kabova A; Stygelbout V; Leroy K; Heraud C; Frédérick C; Suain V; Yilmaz Z; Authelet M; Dedecker R; Potier MC; Duyckaerts C; Brion JP
    J Alzheimers Dis; 2014; 40 Suppl 1():S135-45. PubMed ID: 24614899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accelerated aging exacerbates a pre-existing pathology in a tau transgenic mouse model.
    Bodea LG; Evans HT; Van der Jeugd A; Ittner LM; Delerue F; Kril J; Halliday G; Hodges J; Kiernan MC; Götz J
    Aging Cell; 2017 Apr; 16(2):377-386. PubMed ID: 28160413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversal of neurofibrillary tangles and tau-associated phenotype in the rTgTauEC model of early Alzheimer's disease.
    Polydoro M; de Calignon A; Suárez-Calvet M; Sanchez L; Kay KR; Nicholls SB; Roe AD; Pitstick R; Carlson GA; Gómez-Isla T; Spires-Jones TL; Hyman BT
    J Neurosci; 2013 Aug; 33(33):13300-11. PubMed ID: 23946388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amyloid-β and islet amyloid pathologies link Alzheimer's disease and type 2 diabetes in a transgenic model.
    Wijesekara N; Ahrens R; Sabale M; Wu L; Ha K; Verdile G; Fraser PE
    FASEB J; 2017 Dec; 31(12):5409-5418. PubMed ID: 28808140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.